Online inquiry

IVTScrip™ mRNA-Human AMPH, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK14860MR)

This product GTTS-WK14860MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the AMPH protein. This product can be used in Mitotic arrest phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001635.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 273
UniProt ID P49418
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AMPH, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK14860MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK5327MR IVTScrip™ mRNA-Human CD24, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA CD24
GTTS-WK24697MR IVTScrip™ mRNA-Human ARHGAP35, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARHGAP35
GTTS-WK23712MR IVTScrip™ mRNA-Human APLP2, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA APLP2
GTTS-WK12379MR IVTScrip™ mRNA-Human ABLIM2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ABLIM2
GTTS-WK11591MR IVTScrip™ mRNA-Human ADAM17, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ADAM17
GTTS-WK27773MR IVTScrip™ mRNA-Human ARPP19, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARPP19
GTTS-WK8936MR IVTScrip™ mRNA-Human ADGRE1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADGRE1
GTTS-WK7407MR IVTScrip™ mRNA-Human ADAMTS9, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ADAMTS9
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →